查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2132445

肝病診斷市場規模、佔有率和趨勢分析報告：按診斷方法、疾病、最終用途、地區和細分市場預測（2026-2033 年）

Liver Disease Diagnostics Market Size, Share & Trends Analysis Report By Diagnosis Technique (Imaging, Laboratory Tests, Endoscopy), By Disease (NAFLD, NASH, Fibrosis), By End Use (Hospitals, Laboratories), By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

肝病診斷市場概述

2025年全球肝病診斷市場價值為405億美元，預計將從2026年的432億美元成長到2033年的664億美元，2026年至2033年的年複合成長率（CAGR）為6.3%。

北美市場處於領先地位，預計到 2025 年將佔據最大的銷售佔有率，達到 43.1%。這一成長主要由慢性肝病（如代謝紊亂相關脂肪肝 (MASLD)、病毒性肝炎、肝纖維化、肝硬化和肝細胞癌）的日益普遍所驅動。

非侵入性診斷技術、分子診斷、基於生物標記的檢測以及人工智慧（AI）成像技術的引入，正在加速疾病的早期發現，提高診斷準確性，並為臨床決策提供科學依據。這些進步，加上肝病篩檢計畫的擴展、精準醫療投資的增加以及主要市場參與企業持續的產品創新，有望提升診斷能力並維持市場成長。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 全球肝病診斷市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 全球肝病診斷市場分析工具

第4章：全球肝病診斷市場：依診斷方法分類的估算與趨勢分析

  • 依診斷方法分析全球肝病診斷市場波動。
  • 全球肝病診斷市場規模及趨勢分析（依診斷方法分類，2021-2033 年）
  • 診斷影像
  • 臨床檢測
  • 內視鏡檢查
  • 切片檢查
  • 其他

第5章：全球肝病診斷市場：疾病特異性估算與趨勢分析

  • 全球肝病診斷市場疾病波動分析
  • 全球肝病診斷市場：疾病特定規模與趨勢分析，2021-2033年
  • NAFLD
  • NASH
  • 纖維化
  • 肝硬化
  • HCC
  • 其他

第6章：全球肝病診斷市場：依最終用途分類的估算與趨勢分析

  • 依最終用途分析全球肝病診斷市場波動情形。
    • 全球肝病診斷市場：按最終用途分類的規模和趨勢分析（2021-2033年）
  • 醫院
  • 研究所
  • 其他

第7章 肝病診斷市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第8章 競爭情勢

  • 公司和競爭對手的分類
  • 策略規劃
  • 企業市場占有率分析，2025 年
  • 主要認證機構/方案所有者名單
  • 公司簡介列表
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Randox Laboratories Ltd
    • Boston Scientific Corporation
    • Laboratory Corporation of America Holdings
    • Fujifilm Corporation
    • Horiba Medical
    • Siemens Healthcare GmbH
    • Quest Diagnostics
Product Code: GVR-4-68038-693-6

Liver Disease Diagnostics Market Summary

The global liver disease diagnostics market size was valued at USD 40.5 billion in 2025 and is projected to grow from USD 43.2 billion in 2026 to USD 66.4 billion by 2033, at a CAGR of 6.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 43.1% in 2025. The growth is primarily driven by the increasing prevalence of chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease (MASLD), viral hepatitis, liver fibrosis, cirrhosis, and hepatocellular carcinoma.

The adoption of non-invasive diagnostic technologies, molecular diagnostics, biomarker-based assays, and artificial intelligence-enabled imaging is strengthening early disease detection, improving diagnostic accuracy, and supporting informed clinical decision-making. These advancements, coupled with expanding liver disease screening programs, increasing investments in precision medicine, and continued product innovation by leading market participants, are expected to strengthen diagnostic capabilities and support sustained market growth.

Global Liver Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at global, regional and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global liver disease diagnostics market report on the basis of diagnosis technique, disease, end-use, and region:

  • Diagnosis Technique Outlook (Revenue, USD Billion, 2021 - 2033)
  • Laboratory Tests
  • Imaging
  • Endoscopy
  • Biopsy
  • Others
  • Disease Outlook (Revenue, USD Billion, 2021 - 2033)
  • NAFLD
  • NASH
  • Fibrosis
  • Cirrhosis
  • HCC
  • Others
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Laboratories
  • Others
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Diagnosis Technique Segment
    • 1.2.2. Disease Segment
    • 1.2.3. End-use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Global Liver Disease Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of metabolic and chronic liver diseases
      • 3.2.1.2. Advancements in Diagnostic Technologies
      • 3.2.1.3. Increasing Awareness and Early Detection
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High Cost of Advanced Diagnostics
      • 3.2.2.2. Limited Awareness in Developing Regions
    • 3.2.3. Market opportunity analysis
  • 3.3. Global Liver Disease Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis

Chapter 4. Global Liver Disease Diagnostics Market: Diagnosis Technique Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Liver Disease Diagnostics Market Diagnosis Technique Movement Analysis
  • 4.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Diagnosis Technique, 2021 to 2033 (USD Billion)
  • 4.4. Imaging
    • 4.4.1. Imaging market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.5. Laboratory Tests
    • 4.5.1. Laboratory Tests market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.6. Endoscopy
    • 4.6.1. Endoscopy market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.7. Biopsy
    • 4.7.1. Biopsy market estimates and forecasts 2021 to 2033 (USD Billion)
  • 4.8. Others
    • 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 5. Global Liver Disease Diagnostics Market: Disease Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Liver Disease Diagnostics Market Disease Movement Analysis
  • 5.3. Global Liver Disease Diagnostics Market Size & Trend Analysis, by Disease, 2021 to 2033 (USD Billion)
  • 5.4. NAFLD
    • 5.4.1. NAFLD market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.5. NASH
    • 5.5.1. NASH market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.6. Fibrosis
    • 5.6.1. Fibrosis market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.7. Cirrhosis
    • 5.7.1. Cirrhosis market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.8. HCC
    • 5.8.1. HCC market estimates and forecasts 2021 to 2033 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 6. Global Liver Disease Diagnostics Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Liver Disease Diagnostics Market End-use Movement Analysis
    • 6.2.1. Global Liver Disease Diagnostics Market Size & Trend Analysis, by End-use, 2021 to 2033 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.4. Laboratories
    • 6.4.1. Laboratories market estimates and forecasts 2021 to 2033 (USD Billion)
  • 6.5. Others
    • 6.5.1. Others market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 7. Liver Disease Diagnostics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Billion)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Billion)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2025
  • 8.4. List of Key Certification Providers/Scheme Owners
  • 8.5. Company Profiles/Listing
    • 8.5.1. Abbott
      • 8.5.1.1. Company overview
      • 8.5.1.2. Financial performance
      • 8.5.1.3. Product benchmarking
      • 8.5.1.4. Strategic initiatives
    • 8.5.2. F. Hoffmann-La Roche Ltd.
      • 8.5.2.1. Company overview
      • 8.5.2.2. Financial performance
      • 8.5.2.3. Product benchmarking
      • 8.5.2.4. Strategic initiatives
    • 8.5.3. Thermo Fisher Scientific Inc.
      • 8.5.3.1. Company overview
      • 8.5.3.2. Financial performance
      • 8.5.3.3. Product benchmarking
      • 8.5.3.4. Strategic initiatives
    • 8.5.4. Randox Laboratories Ltd
      • 8.5.4.1. Company overview
      • 8.5.4.2. Financial performance
      • 8.5.4.3. Product benchmarking
      • 8.5.4.4. Strategic initiatives
    • 8.5.5. Boston Scientific Corporation
      • 8.5.5.1. Company overview
      • 8.5.5.2. Financial performance
      • 8.5.5.3. Product benchmarking
      • 8.5.5.4. Strategic initiatives
    • 8.5.6. Laboratory Corporation of America Holdings
      • 8.5.6.1. Company overview
      • 8.5.6.2. Financial performance
      • 8.5.6.3. Product benchmarking
      • 8.5.6.4. Strategic initiatives
    • 8.5.7. Fujifilm Corporation
      • 8.5.7.1. Company overview
      • 8.5.7.2. Financial performance
      • 8.5.7.3. Product benchmarking
      • 8.5.7.4. Strategic initiatives
    • 8.5.8. Horiba Medical
      • 8.5.8.1. Company overview
      • 8.5.8.2. Financial performance
      • 8.5.8.3. Product benchmarking
      • 8.5.8.4. Strategic initiatives
    • 8.5.9. Siemens Healthcare GmbH
      • 8.5.9.1. Company overview
      • 8.5.9.2. Financial performance
      • 8.5.9.3. Product benchmarking
      • 8.5.9.4. Strategic initiatives
    • 8.5.10. Quest Diagnostics
      • 8.5.10.1. Company overview
      • 8.5.10.2. Financial performance
      • 8.5.10.3. Product benchmarking
      • 8.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviation
  • Table 3 U.S. Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 4 U.S. Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 5 U.S. Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 6 North America Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 7 North America Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 8 North America Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 9 North America Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 10 Canada Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 11 Canada Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 12 Canada Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 13 Mexico Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 14 Mexico Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 15 Mexico Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 16 Europe Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 17 Europe Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 18 Europe Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 19 Europe Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 20 UK Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 21 UK Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 22 UK Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 23 Germany Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 24 Germany Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 25 Germany Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 26 France Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 27 France Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 28 France Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 29 Italy Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 30 Italy Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 31 Italy Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 32 Spain Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 33 Spain Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 34 Spain Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 35 Denmark Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 36 Denmark Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 37 Denmark Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 38 Sweden Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 39 Sweden Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 40 Sweden Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 41 Norway Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 42 Norway Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 43 Norway Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 44 Asia Pacific Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 45 Asia Pacific Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 46 Asia Pacific Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 47 Asia Pacific Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 48 Japan Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 49 Japan Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 50 Japan Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 51 China Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 52 China Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 53 China Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 54 India Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 55 India Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 56 India Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 57 Australia Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 58 Australia Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 59 Australia Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 60 South Korea Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 61 South Korea Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 62 South Korea Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 63 Thailand Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 64 Thailand Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 65 Thailand Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 66 Latin America Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 67 Latin America Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 68 Latin America Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 69 Latin America Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 70 Brazil Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 71 Brazil Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 72 Brazil Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 73 Argentina Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 74 Argentina Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 75 Argentina Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 76 MEA Liver Disease Diagnostics market, by region, 2021 - 2033 (USD Billion)
  • Table 77 MEA Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 78 MEA Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 79 MEA Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 80 South Africa Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 81 South Africa Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 82 South Africa Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 83 Saudi Arabia Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 84 Saudi Arabia Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 85 Saudi Arabia Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)
  • Table 86 UAE Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 87 UAE Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 88 Kuwait Liver Disease Diagnostics market, by diagnosis technique, 2021 - 2033 (USD Billion)
  • Table 89 Kuwait Liver Disease Diagnostics market, by disease, 2021 - 2033 (USD Billion)
  • Table 90 Kuwait Liver Disease Diagnostics market, by end use, 2021 - 2033 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Liver disease diagnostics: Market outlook
  • Fig. 9 Liver disease diagnostics: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Liver disease diagnostics market driver impact
  • Fig. 15 Liver disease diagnostics market restraint impact
  • Fig. 16 Liver disease diagnostics market strategic initiatives analysis
  • Fig. 17 Liver disease diagnostics market: disease movement analysis
  • Fig. 18 Liver disease diagnostics market: disease outlook and key takeaways
  • Fig. 19 NAFLD market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 20 NASH market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 21 Fibrosis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 22 Cirrhosis market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 23 HCC market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 25 Liver disease diagnostics market: Diagnosis technique movement analysis
  • Fig. 26 Liver disease diagnostics market: Diagnosis technique outlook and key takeaways
  • Fig. 27 Imaging market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 28 Laboratory tests market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 29 Endoscopy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 30 Biopsy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 31 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 32 Liver disease diagnostics market: End use movement analysis
  • Fig. 33 Liver disease diagnostics market: End use outlook and key takeaways
  • Fig. 34 Hospitals market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 35 Laboratories market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 36 Others market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 37 Global liver disease diagnostics market: Regional movement analysis
  • Fig. 38 Global liver disease diagnostics market: Regional outlook and key takeaways
  • Fig. 39 North America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 40 U.S. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 41 Canada market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 42 Mexico market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 43 Europe market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 44 UK market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 45 Germany market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 46 France market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 47 Italy market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 48 Spain market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 49 Sweden market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 50 Norway market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 51 Denmark market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 52 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 53 Japan market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 54 China market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 55 India market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 56 Australia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 57 Thailand market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 58 South Korea market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 59 Latin America market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 60 Brazil market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 61 Argentina market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 62 Middle East and Africa. market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 64 South Africa market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 65 UAE market estimates and forecasts, 2021 - 2033 (USD Billion)
  • Fig. 66 Kuwait market estimates and forecasts, 2021 - 2033 (USD Billion)